NCT01212991 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 872
- group Id
- BG001
- value
- 845
- group Id
- BG002
- value
- 1717
- units
- Participants
- groups
- description
- Participants received enzalutamide 160 mg, administered as four 40-mg capsules, once per day by mouth.
- id
- BG000
- title
- Enzalutamide
- description
- Participants received placebo, administered as four capsules, once per day by mouth.
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 179
- group Id
- BG001
- value
- 179
- group Id
- BG002
- value
- 358
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 693
- group Id
- BG001
- value
- 666
- group Id
- BG002
- value
- 1359
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.51
- value
- 71.3
- group Id
- BG001
- spread
- 8.42
- value
- 71.2
- group Id
- BG002
- spread
- 8.47
- value
- 71.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 872
- group Id
- BG001
- value
- 845
- group Id
- BG002
- value
- 1717
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 127
- group Id
- BG001
- value
- 120
- group Id
- BG002
- value
- 247
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 27
- title
- Slovakia
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 33
- title
- Finland
- categories
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 81
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 14
- title
- Lithuania
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 18
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 22
- title
- Russian Federation
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 25
- title
- Israel
- categories
- measurements
- group Id
- BG000
- value
- 78
- group Id
- BG001
- value
- 75
- group Id
- BG002
- value
- 153
- title
- United Kingdom
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 30
- title
- Italy
- categories
- measurements
- group Id
- BG000
- value
- 85
- group Id
- BG001
- value
- 90
- group Id
- BG002
- value
- 175
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 91
- group Id
- BG001
- value
- 88
- group Id
- BG002
- value
- 179
- title
- Canada
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- count of participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 872
- group Id
- BG001
- value
- 845
- group Id
- BG002
- value
- 1717
- units
- Participants
- groups
- description
- Participants received enzalutamide 160 mg, administered as four 40-mg capsules, once per day by mouth.
- id
- BG000
- title
- Enzalutamide
- description
- Participants received placebo, administered as four capsules, once per day by mouth.
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 179
- group Id
- BG001
- value
- 179
- group Id
- BG002
- value
- 358
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 693
- group Id
- BG001
- value
- 666
- group Id
- BG002
- value
- 1359
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.51
- value
- 71.3
- group Id
- BG001
- spread
- 8.42
- value
- 71.2
- group Id
- BG002
- spread
- 8.47
- value
- 71.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 872
- group Id
- BG001
- value
- 845
- group Id
- BG002
- value
- 1717
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 127
- group Id
- BG001
- value
- 120
- group Id
- BG002
- value
- 247
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 27
- title
- Slovakia
- categories
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 33
- title
- Finland
- categories
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 81
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 14
- title
- Lithuania
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 18
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 22
- title
- Russian Federation
- categories
- measurements
- group Id
- BG000
- value
- 14
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 25
- title
- Israel
- categories
- measurements
- group Id
- BG000
- value
- 78
- group Id
- BG001
- value
- 75
- group Id
- BG002
- value
- 153
- title
- United Kingdom
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 30
- title
- Italy
- categories
- measurements
- group Id
- BG000
- value
- 85
- group Id
- BG001
- value
- 90
- group Id
- BG002
- value
- 175
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 91
- group Id
- BG001
- value
- 88
- group Id
- BG002
- value
- 179
- title
- Canada
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- count of participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle